21 CFR 520.816

§ 520.816 Epsiprantel.

United States · 21 CFR — Food and Drugs · Status: effective

Cite this

Citation: 21 CFR 520.816, § 520.816 Epsiprantel, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87145
Permanent ID: ys:prov:87145@1
SHA-256: a551dec261090c1a87a9c7f295409456b427ff1e36169f08386a613939750c07

The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.

Full text

(a) Specifications. Each tablet contains either 12.5, 25, 50, or 100 milligrams of epsiprantel. (b) Sponsor. See No. 054771 in § 510.600(c) of this chapter. (c) Conditions of use—(1) Dogs—(i) Amount. 2.5 milligrams per pound of body weight. (ii) Indications for use. Removal of canine cestodes Dipylidium caninum and Taenia pisiformis. (2) Cats—(i) Amount. 1.25 milligrams per pound of body weight. (ii) Indications for use. Removal of feline cestodes D. caninum and T. taeniaeformis. (3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Legislative history

This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.